Skip to main content
. 2023 Sep 14;18(9):e0291523. doi: 10.1371/journal.pone.0291523

Fig 1. Proportion of patients with severe immunodeficiency at ART start, by age group and calendar time period at ART start (n = 2027).

Fig 1